Dr. Gabrielle A. Silver - 16 May 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Dr. Gabrielle A. Silver
Issuer symbol
N/A
Transactions as of
16 May 2022
Net transactions value
+$33,220
Form type
4
Filing time
17 May 2022, 16:04:09 UTC
Previous filing
16 Jun 2021
Next filing
14 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $33,220 +2,500 +13% $13.29 21,343 16 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.